Literature DB >> 28042370

Review of Critical Illness Myopathy and Neuropathy.

Starane Shepherd1, Ayush Batra1, David P Lerner1.   

Abstract

Critical illness myopathy (CIM) and neuropathy are underdiagnosed conditions within the intensive care setting and contribute to prolonged mechanical ventilation and ventilator wean failure and ultimately lead to significant morbidity and mortality. These conditions are often further subdivided into CIM, critical illness polyneuropathy (CIP), or the combination-critical illness polyneuromyopathy (CIPNM). In this review, we discuss the epidemiology and pathophysiology of CIM, CIP, and CIPNM, along with diagnostic considerations such as detailed clinical examination, electrophysiological studies, and histopathological review of muscle biopsy specimens. We also review current available treatments and prognosis. Increased awareness and early recognition of CIM, CIP, and CIPNM in the intensive care unit setting may lead to earlier treatments and rehabilitation, improving patient outcomes.

Entities:  

Keywords:  EMG/NCV; muscular disease; neurocritical care; neuromuscular disease; polyneuropathies

Year:  2016        PMID: 28042370      PMCID: PMC5167093          DOI: 10.1177/1941874416663279

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  64 in total

Review 1.  Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels.

Authors:  M P Fink; T W Evans
Journal:  Intensive Care Med       Date:  2002-02-08       Impact factor: 17.440

2.  Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator.

Authors:  F S Leijten; A W De Weerd; D C Poortvliet; V A De Ridder; C Ulrich; J E Harink-De Weerd
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 3.  Neurologic complications in intensive care.

Authors:  I Barlas; J M Oropello; E Benjamin
Journal:  Curr Opin Crit Care       Date:  2001-04       Impact factor: 3.687

Review 4.  Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis.

Authors:  L H Visser
Journal:  Eur J Neurol       Date:  2006-11       Impact factor: 6.089

5.  Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis.

Authors:  M Mohr; L Englisch; A Roth; H Burchardi; S Zielmann
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

Review 6.  A syndrome of acute severe muscle necrosis in intensive care unit patients.

Authors:  D A Ramsay; D W Zochodne; D M Robertson; S Nag; S K Ludwin
Journal:  J Neuropathol Exp Neurol       Date:  1993-07       Impact factor: 3.685

7.  Critical illness polyneuromyopathy: the electrophysiological components of a complex entity.

Authors:  Josef Bednarik; Zdenek Lukas; Petr Vondracek
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

8.  Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats.

Authors:  Kevin R Novak; Paul Nardelli; Tim C Cope; Gregory Filatov; Jonathan D Glass; Jaffar Khan; Mark M Rich
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

9.  Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading.

Authors:  Monica Llano-Diez; Guillaume Renaud; Magnus Andersson; Humberto Gonzales Marrero; Nicola Cacciani; Henrik Engquist; Rebeca Corpeño; Konstantin Artemenko; Jonas Bergquist; Lars Larsson
Journal:  Crit Care       Date:  2012-10-26       Impact factor: 9.097

Review 10.  Clinical review: intensive care unit acquired weakness.

Authors:  Greet Hermans; Greet Van den Berghe
Journal:  Crit Care       Date:  2015-08-05       Impact factor: 9.097

View more
  22 in total

1.  Sepsis-associated encephalopathy.

Authors:  Dario-Lucas Helbing; Leopold Böhm; Otto W Witte
Journal:  CMAJ       Date:  2018-09-10       Impact factor: 8.262

2.  Critical Illness Polyneuromyopathy and the Diagnostic Dilemma.

Authors:  Sulakshana Sulakshana; Banavathu Kishansing Naik
Journal:  Indian J Crit Care Med       Date:  2020-07

3.  Paraspinal Myositis in Patients with COVID-19 Infection.

Authors:  W A Mehan; B C Yoon; M Lang; M D Li; S Rincon; K Buch
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-06       Impact factor: 3.825

4.  Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report.

Authors:  Julie Byler; Rebecca Harrison; Lindsey L Fell
Journal:  Am J Case Rep       Date:  2021-05-08

5.  Considerations for Postacute Rehabilitation for Survivors of COVID-19.

Authors:  Lisa Mary Sheehy
Journal:  JMIR Public Health Surveill       Date:  2020-05-08

6.  RNA-sequencing reveals altered skeletal muscle contraction, E3 ligases, autophagy, apoptosis, and chaperone expression in patients with critical illness myopathy.

Authors:  Monica Llano-Diez; Wen Fury; Haruka Okamoto; Yu Bai; Jesper Gromada; Lars Larsson
Journal:  Skelet Muscle       Date:  2019-04-16       Impact factor: 4.912

7.  A Well-Structured Follow-Up Program is Required after Recovery from Coronavirus Disease 2019 (COVID-19); Release from Quarantine is Not the End of Treatment.

Authors:  Keun-Mi Lee; Hae-Jin Ko; Geon Ho Lee; A-Sol Kim; Dong-Wook Lee
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

8.  Post-intensive Care Syndrome.

Authors:  Muhammad Hanif Ahmad; Shyh Poh Teo
Journal:  Ann Geriatr Med Res       Date:  2021-06-25

9.  Change in skeletal muscle associated with unplanned hospital admissions in adult patients: A systematic review and meta-analysis.

Authors:  Peter Hartley; Patricia Costello; Rachel Fenner; Nathalie Gibbins; Édáin Quinn; Isla Kuhn; Victoria L Keevil; Roman Romero-Ortuno
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240

10.  Nutrient pattern analysis in critically ill patients using Omics technology (NAChO) - Study protocol for a prospective observational study.

Authors:  Joerg C Schefold; Anna S Messmer; Stefanie Wenger; Lionel Müller; Stephan von Haehling; Wolfram Doehner; Jamie S McPhee; Michaela Fux; Kai M Rösler; Olivier Scheidegger; Radu Olariu; Werner Z'Graggen; Serge Rezzi; Dominik Grathwohl; Tobias Konz; Jukka Takala; Bernard Cuenoud; Stephan M Jakob
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.